Testing the Feasibility of a Self-Help Intervention That Includes Lymphatic Drainage to Reduce Fatigue-Related Symptoms Among Patients with Long COVID in General Practice: Experiences from Our Randomized Controlled Trial (RCT). — CFSMEATLAS
Testing the Feasibility of a Self-Help Intervention That Includes Lymphatic Drainage to Reduce Fatigue-Related Symptoms Among Patients with Long COVID in General Practice: Experiences from Our Randomized Controlled Trial (RCT).
Riste, Lisa, Perrin, Raymond, Mulholland, Thomas et al. · Infectious diseases and therapy · 2026 · DOI
Quick Summary
Researchers tested whether a simple self-help program including gentle massage, stretching, breathing exercises, and temperature therapy could help reduce fatigue in people with long COVID. About 91% of people who were invited agreed to participate in the study. Those who used the self-help program showed slightly more improvement in their fatigue over three months compared to those who didn't receive the program, suggesting this low-cost approach may help some people feel better.
Why It Matters
This study bridges long COVID and ME/CFS research by testing an accessible, low-cost self-help intervention for fatigue—symptoms that often disable patients and have limited treatment options. Finding effective, sustainable interventions that patients can perform independently is critical given the substantial unmet clinical need in both conditions and the potential to reduce healthcare burden.
Observed Findings
90.6% (126/138) of eligible participants consented to the RCT, exceeding the required sample size of 100.
The intervention group showed greater fatigue score improvement at 3 months (−4.6 vs −2.9 in controls, p=0.01).
Follow-up retention was 79.3% at 3 months but declined to 59.4% at 6 months.
Qualitative feedback indicated patients were motivated to participate but found the intervention sometimes burdensome to maintain.
Inferred Conclusions
A low-cost, self-administered intervention combining massage, movement, breathing, and thermal therapy may provide modest fatigue reduction in long COVID patients.
The intervention was generally acceptable and feasible to deliver, with high initial recruitment suggesting patient interest in this approach.
Longer-term adherence and sustainability remain uncertain given the substantial dropout between 3 and 6 months.
Remaining Questions
What factors drive non-adherence and withdrawal between 3 and 6 months, and how can the intervention design be modified to improve long-term engagement?
Does the observed fatigue improvement at 3 months persist beyond 6 months, and what is the optimal intervention frequency and duration?
How does this intervention compare in efficacy to other fatigue management approaches for long COVID and ME/CFS?
What This Study Does Not Prove
This feasibility study does not definitively prove the intervention is effective—it was designed to test recruitment and retention rather than efficacy. The greater improvement in the intervention group compared to control does not account for placebo effects or regression to the mean, and the high 6-month dropout rate limits conclusions about long-term sustainability and benefit.
Tags
Symptom:Fatigue
Phenotype:Long COVID Overlap
Method Flag:Weak Case DefinitionExploratory OnlyMixed Cohort